Publication Name	World Journal of Diabetes
Manuscript ID	100066
Country	Malaysia

Received	2024-08-07 00:11
Peer-Review Started	2024-08-07 01:56
To Make the First Decision
Return for Revision	2024-10-30 08:53
Revised	2024-11-04 10:21
Second Decision	2024-11-15 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-15 08:01
Articles in Press	2024-11-15 08:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-11-22 00:20
Publish the Manuscript Online	2024-11-30 03:48

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Enhancing Metformin Efficacy with Cholecalciferol and Taurine in Diabetes Therapy: Potential and Limitations
Manuscript Source	Invited Manuscript
All Author List	Gehan El-Akabawy and Nabil Eid
Funding Agency and Grant Number
Corresponding Author	Nabil Eid, Assistant Professor, MD, PhD, Department of Anatomy, Division of Human Biology, School of Medicine, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia. nabilsaleheid@imu.edu.my
Key Words	Diabetes; Metformin; Cholecalciferol; Taurine; Hyperglycemia; Oxidative stress; Triglycerides
Core Tip	Diabetes mellitus (DM), particularly type 2 diabetes mellitus (T2DM), poses a significant global health problem. Metformin is commonly used to control hyperglycemia linked to T2DM. Supplementing metformin with cholecalciferol (vitamin D3) and taurine can mitigate diabetes-related complications in a rat model of T2DM by reducing oxidative stress, inflammation, and lipid abnormalities. These findings suggest a synergistic effect between metformin, cholecalciferol, and taurine in managing T2DM complications, potentially offering a more holistic approach to diabetes care
Publish Date	2024-11-30 03:48
Citation	<p>El-Akabawy G, Eid N. Enhancing Metformin Efficacy with Cholecalciferol and Taurine in Diabetes Therapy: Potential and Limitations. <i>World J Diabetes</i> 2025; 16(1): 100066</p>
URL	https://www.wjgnet.com/1948-9358/full/v16/i1/100066.htm
DOI	https://dx.doi.org/10.4239/wjd.v16.i1.100066

Full Article (PDF)	WJD-16-100066-with-cover.pdf
Manuscript File	100066_Auto_Edited_025106.docx
Answering Reviewers	100066-answering-reviewers.pdf
Audio Core Tip	100066-audio.mp3
Conflict-of-Interest Disclosure Form	100066-conflict-of-interest-statement.pdf
Copyright License Agreement	100066-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100066-non-native-speakers.pdf
Peer-review Report	100066-peer-reviews.pdf
Scientific Misconduct Check	100066-scientific-misconduct-check.png
Scientific Editor Work List	100066-scientific-editor-work-list.pdf
CrossCheck Report	100066-crosscheck-report.pdf